Chromocell Therapeutics OverviewChromocell Therapeutics Net Income
Profitability analysis for CHRO.
Quarterly Net Income
-$10.24M
↓ 420.33% YoY
As of Mar 2026
Annual Net Income (TTM)
-$51.59M
↓ 600.88% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...